Healthcare - Biotechnology - NASDAQ - US
$ 0.754
0.533 %
$ 29.8 M
Market Cap
-1.57
P/E
BALANCE SHEET
4.55 M
ASSETS
22.6 M
LIABILITIES
-18.1 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
MiNK Therapeutics, Inc.
| Current Assets | 3.6 M |
| Cash & Short-Term Investments | 3.37 M |
| Receivables | 0 |
| Other Current Assets | 231 K |
| Non-Current Assets | 954 K |
| Long-Term Investments | 0 |
| PP&E | 954 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 11.4 M |
| Accounts Payable | 3.91 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 7.49 M |
| Non-Current Liabilities | 11.2 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 11.2 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 3.4 | 19.6 | 38.9 | 2.7 | 0.3 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 23 K | 0 | 0 |
| Inventory | 0 | 0 | 1.76 K | 1.0 | 87.7 K |
| Other Current Assets | 0.2 | 0.8 | 0.7 | 1.4 | 0.6 |
| Total Current Assets | 3.6 | 20.4 | 39.6 | 4.1 | 0.9 |
| PP&E | 1.0 | 1.1 | 0.6 | 0.5 | 0.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 4.6 | 21.5 | 40.2 | 4.6 | 1.3 |
| LIABILITIES | |||||
| Accounts Payable | 3.9 | 5.8 | 3.0 | 3.1 | 2.5 |
| Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.5 | 6.9 | 13.5 | 10.8 | 4.8 |
| Total Current Liabilities | 11.4 | 12.7 | 16.5 | 14.2 | 7.4 |
| Long Term Debt | 0 | 0 | 0 | 43.8 | 26.8 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 11.2 | 9.2 | 0 | 0.4 | 3.4 |
| Total Liabilities | 22.6 | 21.9 | 16.5 | 58.4 | 37.6 |
| EQUITY | |||||
| Common Stock | 346 | 339 | 335 | 242 | 241 |
| Retained Earnings | (133.4) | (110.9) | (82.9) | (52.7) | (36.5) |
| Other Accumulative Comprehensive Income/Loss | (0.4) | (0.3) | (0.6) | (1.5) | (0.1) |
| Total Equity | (18.1) | (0.4) | 23.8 | (53.9) | (36.3) |
| Total Liabilities and Equity | 4.6 | 21.5 | 40.2 | 4.6 | 1.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 34.4 | 33.7 | 33.5 | 33.1 | 33.1 |